Cell therapy landscape in India: Current advances, opportunities, challenges, and future directions
Year: 2025
Type: article
Abstract: Cell and immunotherapy products are known for targeting the root cause of health ailments and potentially curing cancers and other degenerative indications. The rapid growth in cell therapy products, CRISPR-based gene editing, and stem cell applications in India is changing the face of personalized medicine, putting the country at the forefront of innovative product development. The therapy develops through strong regulatory guidelines and collaborative efforts among academia, industry, and government. However, high costs, less infrastructure, regulatory complexity, and ethics are hurdles in implementing the idea. This review emphasizes the progress made in cell therapy research in India and discusses the challenges as well as the possible strategies for overcoming them.
Source: Chemical Biology Letters
Authors: Tannistha Hota, Swati Verma, Akash Banerjee, Priyajit Saha, Shailender Gugalavath, Deepak Singh
Institution: University of Hyderabad
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413835158